Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing

Author:

Kurstjens Steef1,van der Horst Armando1,Herpers Robert2,Geerits Mick W. L.3,Kluiters-de Hingh Yvette C. M.4,Göttgens Eva-Leonne5,Blaauw Martinus J. T.6,Thelen Marc H. M.578,Elisen Marc G. L. M.49,Kusters Ron110

Affiliation:

1. Laboratory for Clinical Chemistry and Hematology , Jeroen Bosch Hospital , 5223 GZ , Den Bosch , the Netherlands

2. Laboratory of Clinical Chemistry and Hematology , Bernhoven Hospital , Uden , the Netherlands

3. Abnormal Design Ltd , London , UK

4. Laboratory of Clinical Chemistry and Hematology , Elisabeth TweeSteden Hospital , Tilburg , the Netherlands

5. Laboratory of Clinical Chemistry and Hematology , Amphia Hospital , Breda , the Netherlands

6. Department of Internal Medicine , Bernhoven Hospital , Uden , the Netherlands

7. Dutch Foundation for Quality Assessment in Medical Laboratories (SKML) , Nijmegen , the Netherlands

8. Chair in ‘Quality in Medical Laboratory Care’ , Radboud University , Nijmegen , the Netherlands

9. Netherlands Society of Clinical Chemistry and Laboratory Medicine (NVKC) , Utrecht , the Netherlands

10. Department of Health Technology and Services Research , Technical Medical Centre, University of Twente , Enschede , the Netherlands

Abstract

Abstract Objectives The novel coronavirus disease 19 (COVID-19), caused by SARS-CoV-2, spreads rapidly across the world. The exponential increase in the number of cases has resulted in overcrowding of emergency departments (ED). Detection of SARS-CoV-2 is based on an RT-PCR of nasopharyngeal swab material. However, RT-PCR testing is time-consuming and many hospitals deal with a shortage of testing materials. Therefore, we aimed to develop an algorithm to rapidly evaluate an individual’s risk of SARS-CoV-2 infection at the ED. Methods In this multicenter retrospective study, routine laboratory parameters (C-reactive protein, lactate dehydrogenase, ferritin, absolute neutrophil and lymphocyte counts), demographic data and the chest X-ray/CT result from 967 patients entering the ED with respiratory symptoms were collected. Using these parameters, an easy-to-use point-based algorithm, called the corona-score, was developed to discriminate between patients that tested positive for SARS-CoV-2 by RT-PCR and those testing negative. Computational sampling was used to optimize the corona-score. Validation of the model was performed using data from 592 patients. Results The corona-score model yielded an area under the receiver operating characteristic curve of 0.91 in the validation population. Patients testing negative for SARS-CoV-2 showed a median corona-score of 3 vs. 11 (scale 0–14) in patients testing positive for SARS-CoV-2 (p<0.001). Using cut-off values of 4 and 11 the model has a sensitivity and specificity of 96 and 95%, respectively. Conclusions The corona-score effectively predicts SARS-CoV-2 RT-PCR outcome based on routine parameters. This algorithm provides the means for medical professionals to rapidly evaluate SARS-CoV-2 infection status of patients presenting at the ED with respiratory symptoms.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3